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INTRODUCTION 
Asthma is a reversible disease affecting airway. 
More than 300 million people worldwide have asthma 
with morbidity and mortality between 1-8% and 250 
thousand deaths per year. The majority of  asthma 
patients are women (Panek et al., 2016). The number 
of  asthma attacks is highly variable and influenced 
by the climate, so that asthma attacks take place 
according to the cycle. Climate not only affects the 
number but also the severity of  asthma attacks.  Hot 
and dry climate has been shown to decrease the 
number of  attacks but not the severity (Correia Junior 
et al. 2017). In addittion, asthma is also affected by 
physical activity. Epidemiological studies on asthma 
conducted on athletes showed that asthma tend to attack 
athletes who exercise at a high ventilation (Selge et al., 
2016).  Three conditions underlying asthma include 
reversible airway obstruction -either spontaneously or 
with treatment-, airway inflammation, and increased 
responsiveness respiratory tract due to various stimuli 
(Gorczynski & Stanley, 2013). Studies showed that 
many pro inflammatory cells in airway mucosa  were 
found in biopsies of  the epithelial tissue  and lumen 
vessel bronchial blood (Lukawska et al. 2014). Vascular 
tissue increment in the airway affect the severity of  
asthma attacks (Chung & Ferrara 2011; Harkness et 
al. 2014).
Asthma is classified  into eosinophilic, non-
eosinophilic, neutrophilic, and non-neutrophilic. The 
classification is based on the character of  eosinophils 
and neutrophils found in patients with asthma. Patients 
with eosinophilic asthma tend to have severe attacks. 
Airway remodelling in this type is more severe than in 
asthma patients with non eosinophilic phenotype (Fahy, 
2009). This is possible because the neutrophils will 
encourage the activity of  inflammatory mediators and 
vascularization in asthma.Asthma always characterized 
by remodeling of  airway tissue. This remodelling is 
related to the pathological changes in asthma due to 
exposure of  inflammatory mediators. The active mast 
cells mainly secrete histamine, proteases, leukotrienes, 
prostaglandins, platelet activating factor, and various 
cytokines including vascular endothelial growth 
factor (VEGF). The presence of  histamine will cause 
contraction of  airway smooth muscle, mucosal edema, 
and increased mucous secretion. Leukotrienes together 
with prostaglandins and cytokines will cause mucosal 
inflammation. Protease and the formed reactive oxygen 
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species (ROS) resulted  from inflammation lead to the 
damage in the respiratory tract tissue and replaced 
with new, non-functional tissue. This condition causes 
a chronic asthma becomes more severe (Lieberman & 
Anderson 2007). Inflammatory conditions also play 
an  important  role in  airway remodeling in asthma. 
Biopsy results also indicate that in asthma, solid 
vascular network is  formed in sub epithelial layer. The 
evaluation  of  broncho alveolar lavage (BAL) shows a 
great  number of  pro vascularization molecules, vascular 
endothelial growth factor (VEGF). Vascular endothelial 
growth factor (VEGF)  is a molecule that stimulates 
the expansion of  vascular tissue, vasodilatation, and 
plasma leakage (Harkness et al. 2015).
Platelet is a fragment of  the megakaryocytes 
cytoplasm in the blood, ranging from 1-4 um and having 
no nuclei. Platelets have been associated with hemostasis 
(Theml et al., 2004 and Hoffman, 2013). Platelet activity 
can be determined by several indices such as mean platelet 
volume (MPV), platelet distribution width (PDW), and 
plateletcrit (PCT). Increased MPV reflects the impaired 
platelet function and  activation due to the emergence of  
megakaryocytes as compensation for chronic impaired 
production of  platelets.Function of  platelets can not be 
replaced by their precursors, namely megakaryocytes, 
resulting in  functional defect. Plateocrite can be used 
as predictors of  bleeding in addition to the number of  
platelets in the case of  thrombocytopenia. The increase 
in platelet distribution width (PDW) indicates platelet 
anisocytosis (Wiwanitkit 2004); (Tekçe et al. 2015). 
Other studies have shown that MPV can not be used 
to determine the asthma phenotype (Nacaroglu et 
al. 2016). Experimental studies in mice have shown 
that platelets affect the expression of  pro angiogenic 
mediators. Mice with suppressed platelet activity were 
not able to show sufficient angiogenesis (Harkness et 
al. 2015). This is presumably because platelets are part 
of  the inflammatory activators. The lack of  activators 
causes a decrease in the incidence of  inflamation. In 
fact, angiogenesis  is triggered by inflamatory mediator. 
Platelet involvement in remodelling in asthma has 
been well  studied but not the platelet profile using 
a complete blood tests. This is a preliminary study 
to a long-term study to  develop an anti-platelet as a 
treatment for asthma.
RESEARCH METHODS
This study  was a cross-sectional study on medical 
records of  a total of  67 adult patients with asthma 
hospitalized in  Kebumen general hospital between 
January 2016  and  December 2016.  Inclusion criteria 
were all adult inpatients with asthma in Kebumen 
general hospital. The exclusion criteria of  this study 
were asthma patients undergoing oral steroid treatment 
before admission to hospital. The samples were 
divided into two groups: eosinophils of  47 (61.84%) 
and neutrophils group of  20 (26.32%) patients. Data 
taken in this research included medical history and 
physical examination including a history of  asthma, 
the condition of  the attacks, and the current therapy of  
asthma. The laboratory data included complete blood 
test results. The blood sample was taken from cubital 
vein and then inserted into the tube EDTA and screened 
using a hematology analyzer Mindray. The results 
produced a complete data include platelet indices.
STATISTICAL ANALYSIS
Based on the normality test, data were normaly 
distributed. Thus, chi-square test were then performed. 
The data were considered significant if  p <0. 05. The 
ethical clearence was obtained  from  Committee of  
ethics, Faculty of  Medicine, Universitas Islam Indonesia 
(31/Ka.Kom.Et /70/KE/X/2016).
RESULTS 
The study entrolled 67 inpatients of   Kebumen 
general hospital. There were 17 (25. 37%) male and 50 
female (74.63%) subjects. The mean age of  the subjects 
included in this study was 44 years. The majority of  
the subjects did not use reliever regularly during the 
attack (79.10%). 3 subjects (4.48%) used  controller. 
The  detail  characteristics of  the subjects is presented 
in Table 1. The most  common reliever was salbutamol. 
The controllers used were dexametason and budesonide. 
The status was classsified  into 4 categories namely 
eosinophilia, netrophilia, eosinophilia netrophilia, and 
non eosinophilia netrofilia. The table shows the largest 
proportion was in the neutrophilia group (44.74%). 
Chi-square test showed a significant difference (p = 
0.002).
Platelet indices were then evaluated. There was 
a significant difference in levels of  plateletcrit (PCT) 
between neutrophilic and eosinophilic status (p= 0. 
0011). The mean plateletcrit (PCT) of  neutrophilia 
was smaller than eosinophilia.
DISCUSSION
This study showed that there were more patients 
with neutrophilic than eosinophilic asthma.This finding 
supports previous study (Fahy, 2009). Eosinophils 
itself  is a marker of  immune activity against parasitic 
and allergic diseases (Mehta & Hoffbrand, 2014). 
The increase in eosinophils in asthma has  been 
associated with  bronchial mucosal damage and other 
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hiperresponsivity. Studies indicated a relationship 
between eosinophilic asthma phenotype and severe 
inflammation (Berry et al., 2007). Eosinophils affect the 
pathophysiology of  asthma by increasing the released 
inflammatory mediators such as Major Basic Protein 
(MBP), cysteinyl leukotrienes (CysLTs), Reactive oxygen 
species (ROS), and cytokines. This  increase has been 
shown to cause a more severe inflammatory reaction 
in asthma (Athari & Athari, 2014). Mediator released 
also led to the survival of  eosinophils from apoptosis 
leading  to increased in eosinophils (Walsh, 2000). This 
process is mediated by granulocyte-macrophage colony-
stimulating factor (GM-CSF), released by platelets 
(Btech, 2015).
Neutrophil has the same role as eosinophil in 
bronchial hiperactivity. Patients with netrophilic asthma 
experience more severe asthma due  to methacholine 
reactivity (Fahy, 2009). Neutrophils also play a role 
in vascular remodeling in asthma. Thus, it has  been 
assosiated with the status of  patients with chronic 
asthma (Harkness et al., 2015). Neutrophilic characters 
has been associated with respiratory  syncytial virus 
(RSV) (Tauro et al., 2008; Hansbro et al., 2008).
The presence of  more severe inflammation 
manifest in platelet activity. Platelet will have an 
increased activity, indicated by the size of  the granules 
leading to increased secretion of  chemokine. Physically, 
platelets have  been  shown  to seemingly   bigger so 
that   increase MPV (Somuk et al., 2014). However, 
the effect of  MPV on the type of  eosinophilic asthma 
has  not  been  established (Tuncel et al. 2012). Some 
studies showed that  PDW shown a better response 
than  MPV and can  be a specific marker of  coagulation 
(Vagdatli et al., 2010).
Platelet indices including MPV, PDW, and PCT 
can be used as a predictor of  worsening asthma (Sun 
et al,. 2014). However this finding does not supports 
the previous study among children (Tural Kara et al., 
2015). This present study found a significant difference 
in  PCT between eosinophilic and neutrophilic asthma 
phenotype (0.33 ± 0:01 vs. 0:24 ± 0:01). Plateletcrit 
describes the  number of  circulating platelet of  specific 
blood volume. Plateletcrit is similar to  hematocrite 
(Ugur, 2014). The process of  platelet activity appears 
on plateocrite. This is because that the body response 
in platelets appear on this unit (Ergelen & Uyarel, 2014; 
Akpinar et al., 2014).
This difference might  have  been  due  to the 
difference in the  study  subjects used. Research showed 
immunological response in children is stronger than 
that  of  adult (Balduini & Noris, 2014). Changes in 
platelet indices has been strongly associated with some 
Table 1. Characteristics of the Subjects
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diseases in children (Ergul et al., 2016; Tuncel et al., 
2012; Buyukyilmaz et al., 2014; Sun et al. 2014; Shah 
et al. 2017).
This study has shown a significant difference 
in the levels of  PCT between the study groups. The 
study provided an overview of  the opportunities the 
use of  PCT in predicting asthma phenotype.Although 
this study has met the minimum sample size, there 
was a significant difference in another test (number 
of  platelets, MPV, and PDW). Further studies using 
a largerer number of  subjects to find out more about 
whether there are differences in the group.
CONCLUSION
The majority of  the research subjects had 
neutrophilic asthma and only few had eosinophilic 
asthma. In addition, there was a significant difference 
in the PCT level in both study groups.
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